工程化鼻软骨用于修复膝骨关节炎软骨缺损
本研究提出用鼻软骨细胞构建的组织工程软骨(N-TEC)治疗退变性软骨缺损。体外实验显示N-TEC在骨关节炎炎症环境中维持软骨特性并改善炎症谱,机制部分涉及sFRP1下调WNT通路。小鼠和羊模型证实N-TEC存活并 engraft,两名晚期OA患者自体N-TEC移植后14个月无不良反应,疼痛减轻、关节功能和生活质量改善。
要点
- N-TEC在骨关节炎炎症环境中维持软骨特性并改善炎症谱。
- 机制部分涉及sFRP1下调WNT信号通路。
- 两名晚期OA患者自体N-TEC移植后14个月无不良反应且症状改善。
核心结论
- N-TEC可直接促进骨关节炎关节的软骨修复。
- 需开展样本量足够的临床试验评估其治疗OA的疗效。
研究设计与样本
- 体外实验、小鼠异位模型、羊关节软骨缺损模型及两名晚期OA患者的安全性测试。
- 两名患者为Kellgren and Lawrence 3级和4级晚期OA,原考虑单髁膝关节置换术。
主要发现
- N-TEC在体外暴露于骨关节炎关节炎症刺激时维持软骨特性。
- N-TEC可有利地改变骨关节炎关节细胞的炎症谱。
- 该效应至少部分由sFRP1下调WNT信号通路介导。
- N-TEC在小鼠异位模型和羊关节软骨缺损中存活并engraft。
- 两名患者术后14个月无不良反应,报告疼痛减轻、关节功能和生活质量改善。
临床怎么用
- 晚期OA(Kellgren and Lawrence 3–4级)患者可考虑自体N-TEC移植作为替代单髁膝关节置换术的潜在选项。
- 目前证据限于两名患者的安全性观察,疗效需样本量足够的临床试验验证。
局限性
- 临床安全性数据仅来自两名晚期OA患者。
- 疗效尚未在样本量足够的临床试验中评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Osteoarthritis (OA) is the most prevalent joint disorder, causing pain and disability predominantly in the aging population but also affecting young individuals. Current treatments are limited to use of anti-inflammatory drugs to alleviate symptoms or degenerated joint replacement by a prosthetic implant at the end stage of the disease. We hypothesized that degenerative cartilage defects can be treated using nasal chondrocyte–based tissue-engineered cartilage (N-TEC). We demonstrate that N-TEC maintained cartilaginous properties when exposed in vitro to inflammatory stimuli found in osteoarthritic joints and favorably altered the inflammatory profile of cells from osteoarthritic joints. These effects were at least partially mediated by down-regulation of the WNT (wingless/integrated) signaling pathway through sFRP1 (secreted frizzled-related protein-1). We further report that N-TEC survive and engraft in vivo in ectopic mouse models reproducing a human osteochondral OA tissue environment, as well as in sheep articular cartilage defects that mimic degenerative settings. Last, we tested the safety of autologous N-TEC for the treatment of osteoarthritic cartilage defects in the knees of two patients with advanced OA (Kellgren and Lawrence grades 3 and 4) who were otherwise considered for unicondylar knee arthroplasty. No adverse reactions were recorded, and patients reported reduced pain as well as improved joint function and life quality 14 months after surgery. Together, our findings indicate that N-TEC can directly contribute to cartilage repair in osteoarthritic joints. A suitably powered clinical trial is now required to assess its efficacy in the treatment of patients with OA.
引用
- Acevedo Rua L, Mumme M, Manferdini C, et al. Engineered nasal cartilage for the repair of osteoarthritic knee cartilage defects. Sci Transl Med. 2021. PMID: 34516821. doi:10.1126/scitranslmed.aaz4499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。